首页> 美国政府科技报告 >Novel Signaling Perturbation and Ribozyme Gene Therapy Procedure to Block Rho-Kinase (ROK) Activation and Breast Tumor Metastasis
【24h】

Novel Signaling Perturbation and Ribozyme Gene Therapy Procedure to Block Rho-Kinase (ROK) Activation and Breast Tumor Metastasis

机译:新型信号摄动和核酶基因治疗程序阻断Rho激酶(ROK)激活和乳腺肿瘤转移

获取原文

摘要

In this study we have examined CD44 AN HYALURONAN (HA) receptor interaction with a RhoA-specific guanine nucleotide exchange factor (p11 5RhoGEF) in human metastatic breast tumor cells (MDA-MB-23 1 cell line). Immunoprecipitation and immunoblot analyses indicate that both CD44 and P115RhoGEF are expressed in MDA-MB-231 cells, and that these two proteins are physically associated as a complex in vivo. The binding of HA to MDA-MB-231 cells stimulates p115RhoGEF-mediated RhoA signaling and Rho-Kinase (ROK) activity which, in turn, increases serine/threonine phosphorylation of the adaptor protein, Gab-1 (Grb2-associated binder-1). Phosphorylated Gab-1 promotes PI3 kinase recruitment to CD44v3.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号